University Cancer Research Fund
The University Cancer Research Fund (UCRF) is a nation-leading investment to stimulate cancer research and reduce North Carolina’s leading cause of death. The Fund builds upon the exceptional research base at UNC Lineberger Comprehensive Cancer Center, the state’s only public, NCI-designated comprehensive cancer center.
UCRF’s Goal
To create a nation-leading cancer research effort and to reduce North Carolina’s cancer burden. UCRF is accomplishing these goals through:
- Discovery to better understand the causes and course of cancer.
- Innovation to create new and better ways to prevent, diagnose and treat cancer.
- Delivery of improved cancer care, screening and prevention across the state.
Latest News
-
Building tools to help doctors better track patient symptoms, improve outcomes
Digital reporting technologies created by UNC Lineberger researchers are now being used in North Carolina and across the country to improve care and outcomes for cancer patients.
-
UNC Lineberger continues its national leadership in breast cancer research
UNC Lineberger researchers are leading next-generation clinical breast cancer trials as part of a national project using cutting-edge technologies to track tumor changes in real time.
-
‘If you’re trying to make a difference in cancer, you can’t go slow’
Chad Pecot, MD, leads cancer RNA research at UNC Lineberger, creating innovative therapies and promising treatment strategies for multiple cancer mutations.
-
Uniquely engineered KRAS-targeted cancer drug found to be effective in early studies
Chad Pecot, MD, and colleagues have demonstrated that a uniquely engineered drug that zeroes in on a mutated gene called KRAS G12V could potentially stop KRAS-dependent cancers in their tracks.
-
UNC researchers discover an enzyme that protects DNA during rapid cell divisions
Michael Emanuele, PhD, and colleagues have discovered that an enzyme called USP37 plays a crucial role in ensuring our cells copy their DNA correctly.